Prognostic value of HLA class I expression in patients with colorectal cancer. - Wikidata - awgldk - TriplyDB

Prognostic value of HLA class I expression in patients with colorectal cancer.

Prognostic value of HLA class I expression in patients with colorectal cancer.

http://www.wikidata.org/entity/Q35108620

about

Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer.MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.

P2860

Q38928938-3BF97088-235D-4C8E-BA9C-14BC46B36F6D Q47393414-B6FE5CBC-71CF-44B4-B56B-FAF9A70BB4A6 Q50054492-1C377F3B-CC5C-43DC-BD22-7662673B37F0

P2860

Prognostic value of HLA class I expression in patients with colorectal cancer.

http://www.wikidata.org/entity/Q35108620

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Prognostic value of HLA class I expression in patients with colorectal cancer.

@ast

Prognostic value of HLA class I expression in patients with colorectal cancer.

@en

type

label

Prognostic value of HLA class I expression in patients with colorectal cancer.

@ast

Prognostic value of HLA class I expression in patients with colorectal cancer.

@en

prefLabel

Prognostic value of HLA class I expression in patients with colorectal cancer.

@ast

Prognostic value of HLA class I expression in patients with colorectal cancer.

@en

P1433

Q35108620-130EFDCE-7867-40A7-8D89-4781579AE0D9

P1476

Q35108620-FF724AF0-5DF1-42A5-9B14-A5BE7A3B5990

P2093

Q35108620-2E7C4D06-F428-4ECC-B1D0-DBDEEF5FB816

Q35108620-3D550F7C-79CB-4FE3-8F12-87392ECE14AD

Q35108620-9A4B07A5-0A9D-4795-ACE4-0390515B30D8

Q35108620-AE54CAA1-1A74-4B12-84FB-A52346A1F65A

Q35108620-BC43EF7A-8BAA-4870-8E36-98F210127BE7

Q35108620-C70631EC-6EC9-48E3-B0F5-495526F0B9AF

Q35108620-CFC60243-DAD7-41A1-AA49-783F590D6214

Q35108620-D98E9B71-4559-4D7A-8CCD-0CB6F3BCCD8B

Q35108620-FF9F1863-17EF-4178-BE2D-8B5E0EFC59CF

P2860

Q35108620-3BB07310-9E28-42B4-B654-56AA31B42A19

Q35108620-52B7CA15-3CD3-43D4-B006-6ADB8DBE23D8

Q35108620-64DA7679-D7A9-4A7F-AC0F-E0C285586650

Q35108620-68262E52-8529-4D53-BB0D-24A63E9F086D

Q35108620-68E32287-3276-4ED7-BD15-9E43047D1D7C

Q35108620-6AFCCA4A-1875-4A23-BBC8-BBF7399E0FCB

Q35108620-7D1AAD48-FD0B-41C8-9DF8-A8E606117425

Q35108620-8FBD5842-562E-480D-A5D4-C678F8DB0BA0

Q35108620-90D38DED-FA4F-4360-A6CD-C115D8AEB185

Q35108620-A60E8E88-61CB-4ACE-81CA-9B5D327943B6

P2888

Q35108620-EFD294DE-8F6F-4023-9A25-1625E653665E

P304

Q35108620-05F40C2E-FFD9-44CB-B08F-BA757B63BECC

P31

Q35108620-6FFB89E8-54D2-4C12-A020-602C255A9E4D

P356

Q35108620-49895691-0A7F-4F86-9F27-B53710B0FBAC

P478

Q35108620-78F5FAC1-0490-419C-BDA0-9A0DA7CEE4E9

P577

Q35108620-EA4245E0-1AE5-404C-98D2-55515AA4EB9F

P5875

Q35108620-30142BE2-549C-4106-971C-DB652C910E4E

P6179

Q35108620-734BC48E-90BC-4863-BF69-5DADB9A4F9CF

P698

Q35108620-BB672183-0B71-4170-AD4D-BC073CE547F3

P921

Q35108620-ABC54DCB-0C32-4D1F-BEF5-5CE2F2A29448

P932

Q35108620-8D36EF47-E23C-48AA-AF6E-3A0F120296CA

P356

S12957-015-0456-2

P1433

World Journal of Surgical Oncology

P1476

Prognostic value of HLA class I expression in patients with colorectal cancer.

@en

P2093

Koichi Hirata

http://www.w3.org/2001/XMLSchema#string

Masayuki Matsumura

http://www.w3.org/2001/XMLSchema#string

Nobuhiko Toyota

http://www.w3.org/2001/XMLSchema#string

Noriyuki Sato

http://www.w3.org/2001/XMLSchema#string

Tetsuhiro Tsuruma

http://www.w3.org/2001/XMLSchema#string

Tomohisa Furuhata

http://www.w3.org/2001/XMLSchema#string

Toru Mizuguchi

http://www.w3.org/2001/XMLSchema#string

Toshihiko Torigoe

http://www.w3.org/2001/XMLSchema#string

Yuji Iwayama

http://www.w3.org/2001/XMLSchema#string

P2860

Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

HLA class I antigen abnormalities and immune escape by malignant cells.

Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Mechanisms of immune evasion of human neuroblastoma.

Adjuvant treatment of colon cancer: past, present and future.

Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma.

Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.

Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: its association with clinical characteristics and survival after cystectomy.

Efficacy of a continuous venous infusion of fluorouracil and daily divided dose cisplatin as adjuvant therapy in resectable colorectal cancer: a prospective randomized trial.

P2888

s12957-015-0456-2

P304

36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-015-0456-2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273494529

http://www.w3.org/2001/XMLSchema#string

P6179

1046325890

http://www.w3.org/2001/XMLSchema#string

P698

25889416

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4336735

http://www.w3.org/2001/XMLSchema#string